DRUG · Unmapped registry intervention
IKT-001
Find medicine records ·
Find other trials using this name
Clinical trial
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
NCT07365332
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedAn Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Sponsors & collaborators
Inhibikase Therapeuticslead sponsor
Mapped research locations
MadridMadrid, Spain2New YorkNew York, United States1BostonMassachusetts, United States1DallasTexas, United States1St LouisMissouri, United States1NashvilleTennessee, United States1SeoulSouth Korea1LondonUnited Kingdom1CincinnatiOhio, United States1DurhamNorth Carolina, United States1AuroraColorado, United States1LouisvilleKentucky, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07365332 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.